Post Profile

Engine Biosciences Lands $10M for AI-Driven Drug Discovery Platform

Engine Biosciences(“Engine”), a San Francisco, CA-based biotech company pioneering its artificial intelligence and genomics network biomedicine platform for drug discovery has raised $10 million. The seed round was co-led by by DHVC (Danhua Capital) and 6 Dimensions Capital, with participation from global biopharmaceutical leader WuXi AppTec, EDBI, Pavilion Capital, Baidu Ventures, WI Harper, and Nest.
read more


Related Posts raises $2 million for esports digital trading cards

Technology : Venture Beat has raised $2 million in a seed round for its digital trading card platform for esports. It enables users to buy, sell, and collect digital trading cards based on esports athletes, much like collectible cards in traditional... Raises $2M to Launch AI-Powered Medical Matching Service

Medical / Healthcare IT : Healthcare IT Consultant Blog, a San Francisco-based startup has raised $2 million in seed funding co-led by DCM Ventures and Bootstrap Lab to launch a new artificial intelligence engine for doctors. The company has developed a new artificial intellige...

Biotech Startup Lantern Pharma Raises $3.7M to Accelerate Cancer Drug Approval Process

Medical / Healthcare IT : Healthcare IT Consultant Blog

Clinical-stage biotech company Lantern Pharma Inc. has raised $3.7 million in Series A funding led by BIOS Partners, GPG Ventures and other private investors. Using big data and artificial intelligence, Lantern Pharma focused exclus...

Precision BioSciences Raises $25.6M to Expand Genome Editing Platform

Medical / Healthcare IT : Healthcare IT Consultant Blog

Genome editing-based company, Precision BioSciences announced it has closed $25.6 million Series A financing led by venBio. The Research Triangle Park, North Carolina-based company’s oversubscribed round was also joined by Fidelity ...

Engine Biosciences raises $10 million in Southeast Asia’s largest institutional seed round

Technology / Technology Industry News : TechCrunch: Funding and Exits

Life sciences startups in Asia are getting another boost with the $10 million investment in Engine Biosciences — a biotech company that’s applying machine learning to genomics for drug discovery. With its headquarters in both Singap...


Copyright © 2016 Regator, LLC